While deal flow remains even, a $1B+ raise by Roivant Sciences is boosting funding in the European pharma sector to record highs.
Funding is on track for a record high while smart money investors are making calculated, early-stage investments in companies redefining the legal profession.
Despite a recent dip in activity, deals to travel tech startups are on pace for a fourth-consecutive high this year.
Regtech deals have hit 100+ for four consecutive years, and are on pace to reach a new high.
E-commerce subscription startups, which offer products from dog treats to luxury apparel, have seen fluctuating investor interest in recent years.